Literature DB >> 5019640

Serum dopamine-beta-hydroxylase activity in neuroblastoma.

M Goldstein, L S Freedman, A C Bohuon, F Guerinot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5019640     DOI: 10.1056/NEJM197205252862102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Inheritance of very low serum dopamine-beta-hydroxylase activity.

Authors:  R M Weinshilboum; H G Schorott; F A Raymond; W H Weidman; L R Elveback
Journal:  Am J Hum Genet       Date:  1975-09       Impact factor: 11.025

2.  Elevation of plasma dopamine-beta-hydroxylase activity during insulin-induced hypoglycemia in man.

Authors:  F Okada; I Yamashita; N Suwa; H Kunita; S Hata
Journal:  Experientia       Date:  1975-01-15

3.  [Preparations of human dopamine beta hydroxylase subunits and antibodies against these subunits (author's transl)].

Authors:  F Guerinot; C Bohuon
Journal:  Experientia       Date:  1978-06-15

4.  Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell cultures.

Authors:  B Anagnoste; L S Freedman; M Goldstein; J Broome; K Fuxe
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

5.  Dopamine-beta-hydroxylase in patients with cystic fibrosis.

Authors:  M H Schöni; K Türler; H Käser; R Kraemer
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

6.  Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.

Authors:  R J Hsiao; R C Seeger; A L Yu; D T O'Connor
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

7.  Plasma dopamine-beta-hydroxylase in neuroblastoma.

Authors:  M Schöni; H Käser
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

8.  Serum dopamine beta hydroxylase in children with neuroblastoma.

Authors:  B B Eldeeb; S Burns; R Robinson; E M Hammond; J R Mann
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.